Published in N Engl J Med on February 18, 2016
Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone. JAMA (2017) 2.29
Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment. JAMA (2017) 1.73
Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013. JAMA (2017) 1.41
Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ (2016) 0.97
Treatment of Men for "Low Testosterone": A Systematic Review. PLoS One (2016) 0.90
Testosterone Treatment in Older Men. N Engl J Med (2016) 0.89
Testosterone Treatment in Older Men. N Engl J Med (2016) 0.88
Testosterone Treatment in Older Men. N Engl J Med (2016) 0.88
Testosterone Treatment in Older Men. N Engl J Med (2016) 0.87
The rate of change in declining steroid hormones: a new parameter of healthy aging in men? Oncotarget (2016) 0.83
Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial. BMC Med (2016) 0.80
Neuroendocrinology of a Male-Specific Pattern for Depression Linked to Alcohol Use Disorder and Suicidal Behavior. Front Psychiatry (2017) 0.79
Safety, Pharmacokinetics and Pharmacologic Effects of the Selective Androgen Receptor Modulator, GSK2881078, in Healthy Men and Postmenopausal Women. Br J Clin Pharmacol (2017) 0.78
Testosterone Attenuates Age-Related Fall in Aerobic Function in Mobility Limited Older Men With Low Testosterone. J Clin Endocrinol Metab (2016) 0.78
Four Thrombotic Events Over 5 Years, Two Pulmonary Emboli and Two Deep Venous Thrombosis, When Testosterone-HCG Therapy Was Continued Despite Concurrent Anticoagulation in a 55-Year-Old Man With Lupus Anticoagulant. J Investig Med High Impact Case Rep (2016) 0.77
Modifying Risk Factors in the Management of Erectile Dysfunction: A Review. World J Mens Health (2016) 0.77
Age and testosterone mediate influenza pathogenesis in male mice. Am J Physiol Lung Cell Mol Physiol (2016) 0.77
Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle (2016) 0.76
Testosterone therapy in the new era of Food and Drug Administration oversight. Transl Androl Urol (2016) 0.76
Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels. J Clin Endocrinol Metab (2016) 0.76
Establishing a Framework--Does Testosterone Supplementation Help Older Men? N Engl J Med (2016) 0.76
Effect of androgen supplementation on 24-hour activity-rest patterns of aged male rhesus macaques. Neurobiol Aging (2017) 0.75
Familial Longevity Is Not Associated with Major Differences in the Hypothalamic-Pituitary-Gonadal Axis in Healthy Middle-Aged Men. Front Endocrinol (Lausanne) (2016) 0.75
Testosterone replacement therapy and the heart: friend, foe or bystander? Transl Androl Urol (2016) 0.75
Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? Investig Clin Urol (2016) 0.75
Effects of Testosterone Supplementation for 3-Years on Muscle Performance and Physical Function in Older Men. J Clin Endocrinol Metab (2016) 0.75
Effects of Testosterone on Erythropoiesis in a Female Mouse Model of Anemia of Inflammation. Endocrinology (2016) 0.75
Androgen Therapy and Rehospitalization in Older Men With Testosterone Deficiency. Mayo Clin Proc (2016) 0.75
Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy. Transl Androl Urol (2016) 0.75
Comparing the rules of engagement of androgen and glucocorticoid receptors. Cell Mol Life Sci (2017) 0.75
Overselling hysteria: The role of the media and medical journals in promoting questionable risks-a case study of the testosterone controversy. EMBO Rep (2016) 0.75
Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous Testosterone. J Clin Endocrinol Metab (2016) 0.75
[Not Available]. MMW Fortschr Med (2016) 0.75
Re: Effects of Testosterone Treatment in Older Men. Eur Urol (2016) 0.75
Administration of Goji (Lycium chinense Mill.) Extracts Improves Erectile Function in Old Aged Rat Model. World J Mens Health (2016) 0.75
Plasma miRNA expression profile in the diagnosis of late-onset hypogonadism. Asian J Androl (2016) 0.75
Impact of recent FDA ruling on testosterone replacement therapy (TRT). Transl Androl Urol (2016) 0.75
Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss. J Clin Endocrinol Metab (2016) 0.75
Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial. JAMA Intern Med (2017) 0.75
Testosterone Treatment in Older Men. N Engl J Med (2016) 0.75
Predicting low testosterone in aging men: a systematic review. CMAJ (2016) 0.75
A summary of the controversy surrounding off-label medications in men's health. Transl Androl Urol (2016) 0.75
Emotions and Steroid Secretion in Aging Men: A Multi-Study Report. Front Psychol (2017) 0.75
Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Associated With Decreased Incidence of Atrial Fibrillation. J Am Heart Assoc (2017) 0.75
Have the Testosterone Trials demonstrated the effectiveness of testosterone therapy in older men without classical hypogonadism? J R Coll Physicians Edinb (2016) 0.75
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol (1988) 60.71
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25
More powerful procedures for multiple significance testing. Stat Med (1990) 17.12
Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA (2013) 12.37
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst (2006) 9.91
Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab (2001) 7.53
Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther (1974) 7.08
Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One (2014) 6.01
Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ (2007) 5.61
Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab (2008) 3.67
Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage (2002) 3.35
The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res (2002) 3.28
Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med (1997) 3.28
Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab (2010) 3.15
Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab (2004) 3.02
Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab (1999) 2.79
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med (2013) 2.65
An approximate generalized linear model with random effects for informative missing data. Biometrics (1995) 2.34
Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. Eur Heart J (2015) 1.85
The Derogatis Interview for Sexual Functioning (DISF/DISF-SR): an introductory report. J Sex Marital Ther (1997) 1.59
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opin Drug Saf (2014) 1.44
Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci (2011) 1.43
Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab (2005) 1.28
A simple self-report diary for assessing psychosexual function in hypogonadal men. J Androl (2003) 1.19
Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone. J Androl (2007) 1.15
Recruitment and Screening for the Testosterone Trials. J Gerontol A Biol Sci Med Sci (2015) 1.02
Analysis of the efficacy and safety of sildenafil citrate in the geriatric population. BJU Int (2007) 0.95
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med (2007) 20.19
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature (2009) 19.56
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med (2005) 15.18
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med (2011) 13.55
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35
Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care (2007) 12.71
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. Lancet (2011) 12.13
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain (2005) 11.80
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2011) 11.02
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med (2013) 10.74
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care (2007) 8.43
Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr (2008) 7.91
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
World Health Organization reference values for human semen characteristics. Hum Reprod Update (2009) 7.71
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol (2003) 7.49
Association of weight status with mortality in adults with incident diabetes. JAMA (2012) 7.49
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med (2011) 7.42
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med (2003) 7.25
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain (2007) 6.98
Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA (2006) 6.93
The prevention and treatment of missing data in clinical trials. N Engl J Med (2012) 6.92
Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation (2005) 6.89
A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85
Birth weight and risk of type 2 diabetes: a systematic review. JAMA (2008) 6.73
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study. J Clin Oncol (2014) 6.64
Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci (2006) 6.61
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 6.54
Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis Rheum (2004) 6.46
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol (2007) 6.24
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med (2006) 6.14
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med (2013) 5.99
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res (2007) 5.97
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96
Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med (2012) 5.81
Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med (2002) 5.69
Racial differences in incident heart failure among young adults. N Engl J Med (2009) 5.60
The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes (2003) 5.58
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58
Smoking and mortality--beyond established causes. N Engl J Med (2015) 5.54
Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med (2005) 5.49
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol (2011) 5.43
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med (2008) 5.14
High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00
Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA (2011) 4.83
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol (2002) 4.69
Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation (2003) 4.67
Hearing loss and incident dementia. Arch Neurol (2011) 4.65
Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants. Clin Cancer Res (2011) 4.65
BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64